Moderna Inc. (0A45)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 224.50 |
|---|---|
| 52-week range | 22.25 – 242.19 |
| Return, 1 month / 3 months | +40.0% / +276.0% |
| Return, 1 year / 3 years | +710.3% / +115.7% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 105.9% |
| Worst drawdown (1 year) | -33.3% |
| Average daily value traded | 22.83M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Moderna is a biotechnology company that develops medicines and vaccines based on messenger RNA. Its products include vaccines for respiratory viruses and investigational therapies for infectious disease, cancer and rare conditions. The company serves public health authorities, governments and healthcare providers, and it is based in Cambridge, Massachusetts, in the United States.
On this site Moderna Inc. appears as a stock on the London Exchange (UK), code 0A45, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Moderna Inc. (0A45) trades on the London Exchange in UK. It last closed at USD 224.50 on 19 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 343 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 710.3% and over the last three months it rose 276.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 186.5% | ||
| From 52-week high | -5.8% | ||
| Momentum | 100 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 276.0% | ||
| 6-month return | 309.6% | ||
| 12-month return, skipping the last month | 479.0% | ||
| Risk (lower is better) | 23 · Weak | Volatile, with deep drawdowns. | |
| Volatility (1 year) | 105.9% | ||
| Worst drawdown (1 year) | -33.3% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 22.83M USD | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Risk (lower is better): Volatile, with deep drawdowns.
Returns
| 1 week | +4.8% |
|---|---|
| 1 month | +40.0% |
| 3 months | +276.0% |
| 6 months | +309.6% |
| 1 year | +710.3% |
| 3 years | +115.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 156.85 / 78.36 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 17.56 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.